Is it known whether there is a threshold of RAD51C deficiency that is tolerated before associated cancer risks become increased?
The manuscript entitled "Minigene splicing assays identify 20 spliceogenic variants of the breast/ovarian cancer susceptibility gene RAD51C authored by Sanoguera-Miralles et al., is a very interesting study.